000 01499 a2200409 4500
005 20250517184840.0
264 0 _c20190930
008 201909s 0 0 eng d
022 _a1029-2330
024 7 _a10.1080/1061186X.2017.1405427
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGreish, Khaled
245 0 0 _aSildenafil citrate improves the delivery and anticancer activity of doxorubicin formulations in a mouse model of breast cancer.
_h[electronic resource]
260 _bJournal of drug targeting
_c08 2018
300 _a610-615 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntibiotics, Antineoplastic
_xadministration & dosage
650 0 4 _aDisease Models, Animal
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aDrug Delivery Systems
650 0 4 _aDrug Synergism
650 0 4 _aHumans
650 0 4 _aMammary Neoplasms, Experimental
_xpathology
650 0 4 _aMice
650 0 4 _aNanoparticles
650 0 4 _aPhosphodiesterase 5 Inhibitors
_xpharmacology
650 0 4 _aSildenafil Citrate
_xpharmacology
700 1 _aFateel, Maryam
700 1 _aAbdelghany, Sara
700 1 _aRachel, Nanitha
700 1 _aAlimoradi, Houman
700 1 _aBakhiet, Moiz
700 1 _aAlsaie, Ahmed
773 0 _tJournal of drug targeting
_gvol. 26
_gno. 7
_gp. 610-615
856 4 0 _uhttps://doi.org/10.1080/1061186X.2017.1405427
_zAvailable from publisher's website
999 _c27798974
_d27798974